NCT04860713View on ClinicalTrials.gov

An Efficacy and Safety of Proprietary Formulations of Oral Ketamine + Aspirin in Treatment of Acute Headache

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

November 17, 2022

Conditions
Pain
Interventions
DRUG

aspirin and ketamine

Drug: Proprietary oral formulation of 0.85mg/kg of ketamine + 324mg of aspirin

DRUG

Nurtec (Rimegepant)

Drug: 75 mg of ODT

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

All Listed Sponsors
lead

Antonios Likourezos

OTHER